journal article·2023-12-27Open access

Heparin-Induced Allosteric Changes in SARS-CoV-2 Spike Protein Facilitate ACE2 Binding and Viral Entry

Simon J. L. Petitjean, Savannah Eeckhout, Martin Delguste, Qingrong Zhang, Kimberley Durlet, David Alsteens

Nano Letters· Volume 23· Issue 24

Abstract

Understanding the entry of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) into host cells is crucial in the battle against COVID-19. Using atomic force microscopy (AFM), we probed the interaction between the virus's spike protein and heparan sulfate (HS) as a potential attachment factor. Our AFM studies revealed a moderate-affinity interaction between the spike protein and HS on both model surfaces and living cells, highlighting HS's role in early viral attachment. Remarkably, we observed an interplay between HS and the host cell receptor angiotensin-converting enzyme 2 (ACE2), with HS engagement resulting in enhanced ACE2 binding and subsequent viral entry. Our research furthers our understanding of SARS-CoV-2 infection mechanisms and reveals potential interventions targeting viral entry. These insights are valuable as we navigate the evolving landscape of viral threats and seek effective strategies to combat emerging infectious diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: SARS-CoV-2 and COVID-19 Research · Erythrocyte Function and Pathophysiology · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Walloon Brabant 1348, Belgium

WELBIO Department, WEL Research Institute, Wavre, Walloon Brabant 1300, Belgium

Funding

Universit? Catholique de Louvain · Fonds De La Recherche Scientifique - FNRS · H2020 European Research Council

References (49)

Show source-provided references
1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int (accessed 2023-09-01).
2. 10.1126/science.abi799410.1126/science.abi7994 ↗
3. 10.1056/NEJMoa03078110.1056/NEJMoa030781 ↗
4. 10.1038/s41565-020-0732-310.1038/s41565-020-0732-3 ↗
5. 10.1083/jcb.20110813110.1083/jcb.201108131 ↗
6. 10.1126/science.109482310.1126/science.1094823 ↗
7. 10.1038/s41467-020-18319-610.1038/s41467-020-18319-6 ↗
8. 10.1126/science.abb276210.1126/science.abb2762 ↗
9. 10.1016/j.ejim.2020.04.03710.1016/j.ejim.2020.04.037 ↗
10. 10.1016/j.jbc.2021.10084710.1016/j.jbc.2021.100847 ↗
11. 10.1038/s41580-021-00418-x10.1038/s41580-021-00418-x ↗
12. 10.1038/s41564-021-00958-010.1038/s41564-021-00958-0 ↗
13. 10.15252/embj.202110782110.15252/embj.2021107821 ↗
14. 10.1016/j.cell.2020.02.05210.1016/j.cell.2020.02.052 ↗
15. 10.1101/glycobiology.3e.01710.1101/glycobiology.3e.017 ↗
16. 10.1007/s00424-007-0212-810.1007/s00424-007-0212-8 ↗
17. 10.3390/v1107059610.3390/v11070596 ↗
18. 10.1038/nrmicro334610.1038/nrmicro3346 ↗
19. 10.1038/333426a010.1038/333426a0 ↗
20. 10.1021/acs.nanolett.0c0460910.1021/acs.nanolett.0c04609 ↗
21. 10.1126/sciadv.aat127310.1126/sciadv.aat1273 ↗
22. 10.1021/acscentsci.1c0001010.1021/acscentsci.1c00010 ↗
23. 10.1016/j.cell.2020.09.03310.1016/j.cell.2020.09.033 ↗
24. 10.1055/s-0040-172131910.1055/s-0040-1721319 ↗
25. 10.1038/s43586-021-00062-x10.1038/s43586-021-00062-x ↗
26. 10.1021/acs.chemrev.0c0061710.1021/acs.chemrev.0c00617 ↗
27. 10.1126/science.807917510.1126/science.8079175 ↗
28. 10.1126/science.34757510.1126/science.347575 ↗
29. 10.1016/S0006-3495(97)78802-710.1016/S0006-3495(97)78802-7 ↗
30. 10.1016/S0006-3495(95)80441-810.1016/S0006-3495(95)80441-8 ↗
31. 10.1073/pnas.080645110510.1073/pnas.0806451105 ↗
32. 10.1038/nnano.2016.22810.1038/nnano.2016.228 ↗
33. 10.1007/978-1-61779-105-5_1310.1007/978-1-61779-105-5_13 ↗
34. 10.3390/ijms2212657410.3390/ijms22126574 ↗
35. 10.1016/S0092-8674(00)80058-610.1016/S0092-8674(00)80058-6 ↗
36. 10.1016/j.virusres.2013.04.01710.1016/j.virusres.2013.04.017 ↗
37. 10.1007/978-1-4614-7651-1_110.1007/978-1-4614-7651-1_1 ↗
38. 10.1002/smll.20100134910.1002/smll.201001349 ↗
39. 10.1038/nprot.2017.11210.1038/nprot.2017.112 ↗
40. 10.1038/s41467-019-12411-210.1038/s41467-019-12411-2 ↗
41. 10.1073/pnas.222074112010.1073/pnas.2220741120 ↗
42. 10.7861/clinmed.2020-035110.7861/clinmed.2020-0351 ↗
43. 10.1038/s41586-022-04474-x10.1038/s41586-022-04474-x ↗
44. 10.3390/v1502027110.3390/v15020271 ↗
45. 10.1161/01.CIR.23.4.57810.1161/01.CIR.23.4.578 ↗
46. 10.1016/j.jcrc.2023.15434410.1016/j.jcrc.2023.154344 ↗
47. 10.1016/j.redox.2020.10161510.1016/j.redox.2020.101615 ↗
48. 10.15252/embj.202010511410.15252/embj.2020105114 ↗
49. 10.3389/fimmu.2021.78135210.3389/fimmu.2021.781352 ↗